ConductScience.org, home

Paper41920375

Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases.

Cai L and 6 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases. Papers, record 41920375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41920375

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cai LLianqing
2Hao YYifei
3Shio NPNise Pantaleo
4Tang SSiyu
5Wang XXiu
6Li ZZegeng
7Zhu JJie

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Extracellular TrapsMajor topic
Lung DiseasesMajor topic
NeutrophilsMajor topic
ImmunotherapyMajor topic
Humans
Animals
Immunity, Innate
Histones

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82575021the National Natural Science Foundation of ChinaPubMed
2408085MH230the Science Fund for Anhui Provincial Natural Science FoundationPubMed
2022AH020044Distinguished Young Scholars in Universities of Anhui ProvincePubMed

Source PubMed

Download CSV of grants

References100

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139127273Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment.Int J Biol Macromol2024https://conductscience.org/library/papers/39127273PubMed
239905519"The NET effect": Neutrophil extracellular traps-a potential key component of the dysregulated host immune response in sepsis.Crit Care2025https://conductscience.org/library/papers/39905519PubMed
322802447Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus.J Leukoc Biol2012https://conductscience.org/library/papers/22802447PubMed
439300084Neutrophil extracellular traps in homeostasis and disease.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39300084PubMed
520733033PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps.J Exp Med2010https://conductscience.org/library/papers/20733033PubMed
628513453Chronic obstructive pulmonary disease.Lancet2017https://conductscience.org/library/papers/28513453PubMed
740783798The role of long non-coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications.Clin Transl Med2025https://conductscience.org/library/papers/40783798PubMed
836979018The NADPH Oxidase Inhibitors Apocynin and Diphenyleneiodonium Protect Rats from LPS-Induced Pulmonary Inflammation.Antioxidants (Basel)2023https://conductscience.org/library/papers/36979018PubMed
938637878Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.J Biomed Sci2024https://conductscience.org/library/papers/38637878PubMed
1030279690Physiological Stimuli Induce PAD4-Dependent, ROS-Independent NETosis, With Early and Late Events Controlled by Discrete Signaling Pathways.Front Immunol2018https://conductscience.org/library/papers/30279690PubMed
1134260389DNAse-dependent, NET-independent pathway of thrombus formation in vivo.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34260389PubMed
1240967767Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.Eur Respir J2025https://conductscience.org/library/papers/40967767PubMed
1317632569Beneficial suicide: why neutrophils die to make NETs.Nat Rev Microbiol2007https://conductscience.org/library/papers/17632569PubMed
1432296583Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis.Cancer Biol Med2020https://conductscience.org/library/papers/32296583PubMed
1536703990Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function.Front Immunol2022https://conductscience.org/library/papers/36703990PubMed
1641531731Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survival.iScience2026https://conductscience.org/library/papers/41531731PubMed
1722817992Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1.Cell Host Microbe2012https://conductscience.org/library/papers/22817992PubMed
1837356776Substrate-dependent metabolomic signatures of myeloperoxidase activity in airway epithelial cells: Implications for early cystic fibrosis lung disease.Free Radic Biol Med2023https://conductscience.org/library/papers/37356776PubMed
1938336251
Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled single- and multiple-dose escalation study in Chinese healthy subjects.
Eur J Pharm Sci2024https://conductscience.org/library/papers/38336251PubMed
2010843967Neutrophil elastase induces MUC5AC messenger RNA expression by an oxidant-dependent mechanism.Chest2000https://conductscience.org/library/papers/10843967PubMed

See all 100 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42875839PDHA1 Hyperactivation-Mediated Glucose Metabolism Reprogramming Fuels Neutrophil NETosis and Promotes Acute Lung Injury.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42875839

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41920375

GET https://conductscience.org/api/papers/v1/41920375/references?page=2